Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01294449 · ClinicalTrials.gov registry record
Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Post Approval Registry
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 394
- Enrollment target
NCT01294449: Completed study, sponsored by Boston Scientific Corporation.
NCT01294449 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 394 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01294449 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 394 participants
- Enrollment target
Study Summary
MADIT-CRT PAR is an FDA mandated follow-up registry for patients that participated in the MADIT-CRT IDE study examining long-term mortality. (MADIT-CRT IDE: NCT00180271)
Primary Outcome
Outcome measured for total population. Not broken down by indication received.
Interventions
- DEVICE MADIT-CRT ICD
- DEVICE MADIT-CRT CRT-D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 394 participants |
| Start Date | 2011-03 |
| Est. Completion | 2013-11 |
What the finished NCT01294449 record still lists
NCT01294449 is an observational study that tracks outcomes without assigning an intervention. The registered 394 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which MADIT-CRT ICD is the first listed.
NCT01294449 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01294449 about?
NCT01294449 is a clinical study titled "Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Post Approval Registry". MADIT-CRT PAR is an FDA mandated follow-up registry for patients that participated in the MADIT-CRT IDE study examining long-term mortality. (MADIT-CRT IDE: NCT00180271)
What is the current status of trial NCT01294449?
This trial is currently completed. The enrollment target is 394 participants. The study started on 2011-03. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01294449?
The interventions under investigation include: MADIT-CRT ICD (DEVICE), MADIT-CRT CRT-D (DEVICE).
Who is sponsoring clinical trial NCT01294449?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06657924 · 394 participants · Phase 2
Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery
- NCT07225660 · 394 participants · NA
Hormonal Optimization: Late vs. Immediate Start After Discontinuation of Oral Contraceptives in Assisted Reproductive technologY (HOLIDAY)
- NCT07207369 · 395 participants · Phase 3
A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars
- NCT05640999 · 393 participants · Phase 2
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia